| Line Item | Jun 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||||
| Research and development costs | — | — | ||||||
| General and administrative | ||||||||
| Depreciation and amortization | — | — | ||||||
| Total Operating Expenses | — | — | ||||||
| OPERATING LOSS | ||||||||
| OTHER INCOME (EXPENSE) | ||||||||
| Government grants | — | — | ||||||
| Interest and dividend income | — | — | ||||||
| Foreign exchange (loss) gain | — | — | ||||||
| OTHER INCOME (EXPENSE) | ||||||||
| Net loss before income tax | — | — | ||||||
| Net loss | ||||||||
| Loss per common share, basic (in dollars per share) | — | — | ||||||
| Loss per common share, diluted (in dollars per share) | — | — |